These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16215760)

  • 21. Mometasone furoate hydrogel for scalp use: in vitro and in vivo evaluation.
    Salgado A; Raposo S; Marto J; Silva AN; Simões S; Ribeiro HM
    Pharm Dev Technol; 2014 Aug; 19(5):618-22. PubMed ID: 23869426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mometasone versus betamethasone creams: a trial in dermatoses.
    Wishart JM; Lee IS
    N Z Med J; 1993 May; 106(956):203-5. PubMed ID: 8341439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical mometasone furoate for vulvar lichen sclerosus.
    Cattaneo A; De Magnis A; Botti E; Sonni L; Carli P; Taddei GL
    J Reprod Med; 2003 Jun; 48(6):444-8. PubMed ID: 12856516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of activity of different topical corticosteroid creams and ointments using a vasoconstriction assay: superiority of hydrocortisone butyrate over hydrocortisone].
    Korting HC; Maslen K; Gross G; Willers C
    J Dtsch Dermatol Ges; 2005 May; 3(5):348-53. PubMed ID: 16372801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mometasone furoate decreases adhesion molecule expression in psoriasis.
    Berti E; Cerri A; Marzano AV; Richelda R; Bianchi B; Caputo R
    Eur J Dermatol; 1998 Sep; 8(6):421-6. PubMed ID: 9729054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate.
    Femenía-Font A; Balaguer-Fernández C; Merino V; Rodilla V; López-Castellano A
    Eur J Pharm Biopharm; 2005 Sep; 61(1-2):50-5. PubMed ID: 15925502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absorption of hydrocortisone from the skin reservoir in atopic dermatitis.
    Turpeinen M
    Br J Dermatol; 1991 Apr; 124(4):358-60. PubMed ID: 2025556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response of cutaneous microcirculation to treatment with mometasone furoate in patients with psoriasis.
    Stinco G; Lautieri S; Piccirillo F; Valent F; Patrone P
    Clin Exp Dermatol; 2009 Dec; 34(8):915-9. PubMed ID: 19486040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studying the effectiveness of penetration enhancers to deliver retinol through the stratum cornum by in vivo confocal Raman spectroscopy.
    Mélot M; Pudney PD; Williamson AM; Caspers PJ; Van Der Pol A; Puppels GJ
    J Control Release; 2009 Aug; 138(1):32-9. PubMed ID: 19401210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of elicitation of contact dermatitis in humans by mometasone furoate: evaluation by means of 20-MHz B scanning associated with image analysis.
    Di Nardo A; Giusti G; Mantovani L; Bianchi B; Seidenari S
    Dermatology; 1997; 195(2):137-41. PubMed ID: 9310720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous penetration of hydrocortisone in humans following skin delipidization by 1:1:1 trichloroethane.
    Bucks DA; Maibach HI; Menczel E; Wester RC
    Arch Dermatol Res; 1983; 275(4):242-5. PubMed ID: 6625650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Remarks on the percutaneous absorption of corticoids].
    Rimbaud P; Meynadier J
    Ann Dermatol Syphiligr (Paris); 1968; 95(3):263-7. PubMed ID: 5697207
    [No Abstract]   [Full Text] [Related]  

  • 33. The importance of the cosolvent propylene glycol on the antimicrobial preservative efficacy of a pharmaceutical formulation by DOE-ruggedness testing.
    De Spiegeleer B; Wattyn E; Slegers G; Van der Meeren P; Vlaminck K; Van Vooren L
    Pharm Dev Technol; 2006; 11(3):275-84. PubMed ID: 16895838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-inflammatory activity of inhaled mometasone furoate in allergic mice.
    Chapman RW; Sehring SJ; Garlisi CG; Falcone A; Kung TT; Stelts D; Minnicozzi M; Jones H; Umland S; Egan RW; Kreutner W
    Arzneimittelforschung; 1998 Apr; 48(4):384-91. PubMed ID: 9608881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical Lyogel Containing Corticosteroid Decreases IgE Expression and Enhances the Therapeutic Efficacy Against Atopic Eczema.
    Ng SF; Anuwi NA; Tengku-Ahmad TN
    AAPS PharmSciTech; 2015 Jun; 16(3):656-63. PubMed ID: 25511806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Percutaneous absorption of diflucortolone valerate in guinea pigs and man (author's transl)].
    Täuber VU
    Arzneimittelforschung; 1976; 26(7b):1479-84. PubMed ID: 1036943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous permeability of 1-phenoxy-2-propanol, a preservative in cosmetics.
    Lee JD; Kim JY; Jang HJ; Lee BM; Kim KB
    Regul Toxicol Pharmacol; 2019 Apr; 103():56-62. PubMed ID: 30611821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous absorption of butylparaben through guinea pig skin in vitro.
    Komatsu H; Suzuki M
    J Pharm Sci; 1979 May; 68(5):596-8. PubMed ID: 430497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical safety and vasoconstrictive assay-based bioequivalence of a new reformulated mometasone cream.
    Krishna R; Horowitz A; Larson P; Bolognese J; Marcantonio EE
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1173-1177. PubMed ID: 28277845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dimethylacetamide (DMAC) and dimethylformamide (DMFA). Effect on percutaneous absorption.
    Munro DD; Stoughton RB
    Arch Dermatol; 1965 Nov; 92(5):585-6. PubMed ID: 5844405
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.